Survival outcome of different treatment sequences in patients with locally advanced and metastatic pancreatic cancer

Table 2 Chemotherapy regimens received

Chemotherapy regimens received	N	%
First-line	285	100
NabP/S-1	166	58
NabP/Gem	23	8
Gem/Oxaliplatin	16	6
FOLFIRINOX	28	10
Gem alone	19	7
Other therapies	33	12
Second-line therapy	285	100
Gem combined therapy	136	48
FOLFIRINOX	28	10
Gem alone	19	7
NabP combined therapy	54	19
Other therapies	48	17
Death after 2nd-line or not suitable for 3rd-line	148	52
Third-line treatment	137	100
FOLFIRINOX	43	31
Immunotherapy	26	19
Gem combined therapy	14	10
Irinotecan or Oxaliplatin combined therapy	31	23
Other therapies	23	17
Fourth-line therapy	30	100

ISSN: 1471-2407